Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Brand

Showing results (431-440 of 437) with videos related to

Pageof 44
Sort By:
You have reached the last page of results.This site can display upto 437 results.
Journal of Medicinal Chemistry|February 8, 2002
Novel tricyclic-alpha-alkyloxyphenylpropionic acids: dual PPARalpha/gamma agonists with hypolipidemic and antidiabetic activityPer Sauerberg, Ingrid Pettersson, Lone Jeppesen, et al.
Journal of Medicinal Chemistry|December 13, 2002
Optimization of alkylidene hydrazide based human glucagon receptor antagonists. Discovery of the highly potent and orally available 3-cyano-4-hydroxybenzoic acid [1-(2,3,5,6-tetramethylbenzyl)-1H-indol-4-ylmethylene]hydrazidePeter Madsen, Anthony Ling, Michael Plewe, et al.
ACS Pharmacology & Translational Science|June 18, 2026
Interaction between Paracetamol Glucuronide and a Glucose-Sensitive Insulin Molecule (NNC2215): Increased Risk of HypoglycemiaJeppe Sturis, Lene Alifrangis, Peter K Nielsen, et al.
NPJ Digital Medicine|June 2, 2026
Human expertise or artificial intelligence? A prospective study on nail disorder diagnosisFlurin L Brand, Ali Mokhtari, Simone Cazzaniga, et al.
Diabetologia|November 20, 2022
Preclinical exploration of combined glucagon inhibition and liver-preferential insulin for treatment of diabetes using in vitro assays and rat and mouse modelsHenning Hvid, Christian L Brand, Tina Hummelshøj, et al.
Nature|October 16, 2024
Glucose-sensitive insulin with attenuation of hypoglycaemiaThomas Hoeg-Jensen, Thomas Kruse, Christian L Brand, et al.
Plos Pathogens|December 9, 2024
A potent and selective reaction hijacking inhibitor of Plasmodium falciparum tyrosine tRNA synthetase exhibits single dose oral efficacy in vivoStanley C Xie, Chia-Wei Tai, Craig J Morton, et al.
Pageof 44

Showing results (431-440 of 437) with videos related to

Sort By:
Pageof 44
You have reached the last page of results.This site can display upto 437 results.
Journal of Medicinal Chemistry|February 8, 2002
Novel tricyclic-alpha-alkyloxyphenylpropionic acids: dual PPARalpha/gamma agonists with hypolipidemic and antidiabetic activityPer Sauerberg, Ingrid Pettersson, Lone Jeppesen, et al.
Journal of Medicinal Chemistry|December 13, 2002
Optimization of alkylidene hydrazide based human glucagon receptor antagonists. Discovery of the highly potent and orally available 3-cyano-4-hydroxybenzoic acid [1-(2,3,5,6-tetramethylbenzyl)-1H-indol-4-ylmethylene]hydrazidePeter Madsen, Anthony Ling, Michael Plewe, et al.
ACS Pharmacology & Translational Science|June 18, 2026
Interaction between Paracetamol Glucuronide and a Glucose-Sensitive Insulin Molecule (NNC2215): Increased Risk of HypoglycemiaJeppe Sturis, Lene Alifrangis, Peter K Nielsen, et al.
NPJ Digital Medicine|June 2, 2026
Human expertise or artificial intelligence? A prospective study on nail disorder diagnosisFlurin L Brand, Ali Mokhtari, Simone Cazzaniga, et al.
Diabetologia|November 20, 2022
Preclinical exploration of combined glucagon inhibition and liver-preferential insulin for treatment of diabetes using in vitro assays and rat and mouse modelsHenning Hvid, Christian L Brand, Tina Hummelshøj, et al.
Nature|October 16, 2024
Glucose-sensitive insulin with attenuation of hypoglycaemiaThomas Hoeg-Jensen, Thomas Kruse, Christian L Brand, et al.
Plos Pathogens|December 9, 2024
A potent and selective reaction hijacking inhibitor of Plasmodium falciparum tyrosine tRNA synthetase exhibits single dose oral efficacy in vivoStanley C Xie, Chia-Wei Tai, Craig J Morton, et al.
Pageof 44